Alzheimers disease identification with the PHERAstar FSX | BMG LABTECH

- Company/University: ARUK Oxford Drug Discovery Institute, Oxford University, UK - Interviewee: Dr Emma Murphy (Assay Development & Screening Team Leader) - Products used: PHERAstar FSX - Method: HTS, protein-protein interaction, AlphaLISA The Oxford Drug Discovery Institute is funded by Alzheimer´s Research UK (ARUK) and focuses on various areas of neurodegenerative disease research. Emma´s work is mainly targeted onto Alzheimer´s and Parkinson´s diseases. Aim of the institute is bridging the.